FA: A critical appraisal of the JUPITER study of rosuvastatin and CVD
Tuesday 20th July 2010
The JUPITER trial suggested that rosuvastatin is effective for primary prevention of cardiovascular mortality. A recent re-analysis and critical appraisal s doubt on that conclusion. The trial was stopped early due to an apparent benefit that was likely a statistical error. More...